ArticleScientific reports2026
Characterization of conserved residues in the mammarenavirus matrix protein Z using novel Lassa virus life cycle modelling assays.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lassa virus (LASV) is the causative agent of Lassa fever, which causes thousands of deaths every year within the endemic regions of West Africa. Despite its discovery over half a century ago, our knowledge regarding basic steps in the LASV life cycle remains limited. In order to simplify studying basic principles of the LASV life cycle, we developed a novel transcription- and replication-competent virus-like particle (trVLP) system that can model the whole virus life cycle using only authentic LASV components but without the need for a maximum containment laboratory. As a proof-of-concept we used this system, together with classical minigenome systems, to determine the functional contributions of highly conserved amino acids within the mammarenavirus matrix protein Z. We could demonstrate that residues L71 and P72 are essential for the role of Z in inhibiting viral RNA synthesis, with residues R16, D22, K68 and T73 also contributing to this function. Additionally, we showed that L71-T73 mediate interaction of Z with the viral nucleoprotein (NP), which is also supported by residue G2. Given the critical role of these interactions in the virus life cycle, understanding these amino acids’ functions will help to define potential targets for the development of urgently needed countermeasures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.